Skip to main content

Selected Grants


ABL kinase inhibition sensitizes SCLC to dysregulation of metabolic pathways leading to cell death

FellowshipPI-Fellow · Awarded by National Institutes of Health · 2024 - 2026

Uncovering novel vulnerabilities to treat SCLC therapy resistance

ResearchResearch Assistant · Awarded by Lung Cancer Research Foundation · 2023 - 2025